In response, brands like Hims & Hers and Eden have already announced that they will no longer offer certain compounded GLP-1s, and Ro dropped all compounded weight-loss options from its site (after striking a deal with Zepbound manufacturer Eli Lilly)
Evernorth recently expanded the program with the creation of a new program called Evernorth EnReachRx, a patient support clinical model enabled by pharmacies for dispensing GLP-1 prescription medications backed by optimized drug spend management. Elevance Health introduced a comprehensive weight management program through its pharmacy benefit manager, CarelonRx
[48] Analysis results of racemic ethyl 4-chloro-3-hydroxybutyrate are as follows: [49] 1 H-NMR (CDCl 3 ) = 1.28 (3H,t), 2.62 (2H,d), 3.53 (lH,br), [50] 3.60 (2H,d), 4.20 (2H,q), 4.33 (lH,m) [51] [52] Example 3: Preparation of ethyl (RV4-chloro-3-hvdroxybutyrate (4) [53] 40 g (10% w/v) of racemic ethyl 4-chloro-3-hydroxybutyrate was added to a flask containing 360 mL of 0.1M potassium phosphate buffer (pH 8.0) to which 4 g (1% w/ v) of immobilized lipase Novozyme 435 was then added, followed by reacting at 30 0 C
It specifically encourages the production of Type I and Type III collagen, which are vital for making skin strong yet flexible
